Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3389/fphar.2016.00283
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2016
- Creator
- DOI
-
10.18154/RWTH-CONV-210844
- URN
-
urn:nbn:de:101:1-2019082906163689768409
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schon, Hans-Theo
- Weiskirchen, Ralf
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2016
Other Objects (12)
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Cell therapy in liver fibrosis
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Cell therapy in liver fibrosis
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Established Hepatic Stellate Cell Lines in Hepatology Research
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9